Radiation after lung lining surgery for spread cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a type of radiation therapy (hemithoracic arc radiotherapy) for people whose cancer has spread beyond the lung and who have already had surgery to remove the lining of the lung. The goal is to see if this radiation helps control the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have cancer that has spread to other parts of your body (metastatic).
- You must have had surgery to remove the lining of your lung (pleural decortication).
- You cannot have severe breathing problems (poor lung function).
- This cannot be for cancer that has come back or for comfort care only.
- You must be able to come for daily radiation treatments and follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether treating each spot of cancer that has spread (but only a few spots) with focused radiation can help control breast cancer. It aims to see if this approach can stop the cancer from growing further without needing strong whole-body treatments right away.
This trial tests if a partial surgery called pleurectomy can help people with a specific type of mesothelioma that cannot be fully removed. You must have already completed at least 6 weeks of chemotherapy or immunotherapy without the cancer growing.
This trial tests if giving radiation after surgery can help people with non-small cell lung cancer that has spread to multiple lymph nodes in the chest. It may offer a treatment option for those who have not had chemotherapy or immunotherapy before.
This trial tests a new radiation technique for people with cancer that has spread to bones or soft tissues in the chest, belly, or pelvis. The goal is to safely deliver effective palliative radiation to ease symptoms.
This Phase 2 study tests a precise type of chest radiation that targets cancer in the lung lining (pleura) while trying to protect healthy lungs and organs. It may help people with thymic cancer that has spread to the pleura, including cases that return after prior treatment.
This trial studies whether adding a targeted course of radiation to the prostate area after initial systemic treatment can improve outcomes for people with metastatic prostate cancer. It may help control the cancer by treating remaining disease after medicines have started working.
Hear when a new Malignant Pleural Mesothelioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.